Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 301

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts

Open access
Loupy, Alexandre, Vernerey, Dewi, Tinel, Claire, Aubert, Olivier, Duong van Huyen, Jean-Paul, Rabant, Marion, Verine, Jérôme, Nochy, Dominique, Empana, Jean-Philippe, Martinez, Frank, Glotz, Denis, Jouven, Xavier, Legendre, Christophe, Lefaucheur, Carmen·2015·Journal of the American Society of Nephrology

Abstract

Kidney allograft rejection can occur in clinically stable patients, but long-term significance is unknown. We determined whether early recognition of subclinical rejection has long-term consequences for kidney allograft survival in an observational prospective cohort study of 1307 consecutive nonselected patients who underwent ABO-compatible, complement-dependent cytotoxicity-negative crossmatch kidney transplantation in Paris (2000-2010). Participants underwent prospective screening biopsies at 1 year post-transplant, with concurrent evaluations of graft complement deposition and circulating anti-HLA antibodies. The main analysis included 1001 patients. Three distinct groups of patients were identified at the 1-year screening: 727 (73%) patients without rejection, 132 (13%) patients with subclinical T cell-mediated rejection (TCMR), and 142 (14%) patients with subclinical antibody-mediated rejection (ABMR). Patients with subclinical ABMR had the poorest graft survival at 8 years post-transplant (56%) compared with subclinical TCMR (88%) and nonrejection (90%) groups (P<0.001). In a multivariate Cox model, subclinical ABMR at 1 year was independently associated with a 3.5-fold increase in graft loss (95% confidence interval, 2.1 to 5.7) along with eGFR and proteinuria (P<0.001). Subclinical ABMR was associated with more rapid progression to transplant glomerulopathy. Of patients with subclinical TCMR at 1 year, only those who further developed de novo donor-specific antibodies and transplant glomerulopathy showed higher risk of graft loss compared with patients without rejection. Our findings suggest that subclinical TCMR and subclinical ABMR have distinct effects on long-term graft loss. Subclinical ABMR detected at the 1-year screening biopsy carries a prognostic value independent of initial donor-specific antibody status, previous immunologic events, current eGFR, and proteinuria.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1681/asn.2014040399

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 301

Metadata

Authors
Loupy, A., Vernerey, D., Tinel, C., Aubert, O., Duong van Huyen, J.-P., Rabant, M., Verine, J., Nochy, D., Empana, J.-P., Martinez, F., Glotz, D., Jouven, X., Legendre, C., & Lefaucheur, C.
Venue
Journal of the American Society of Nephrology
Published
2015-07
Volume
26
Issue
7
Pages
1721-1731
ISSN
1046-6673 (ISSN-L)
OpenAlex
W2122930177
Cited by
301
References
25
FWCI
26.19
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts. https://app.cochat.ai/papers/10.1681/asn.2014040399
The paper
Loupy, A., Vernerey, D., Tinel, C., Aubert, O., Duong van Huyen, J.-P., Rabant, M., Verine, J., Nochy, D., Empana, J.-P., Martinez, F., Glotz, D., Jouven, X., Legendre, C., & Lefaucheur, C. (2015). Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2014040399

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.